SI, sucrase-isomaltase, 6476

N. diseases: 117; N. variants: 15
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Sucrase-isomaltase deficiency, congenital
0.790 Biomarker disease CTD_human
CUI: C0024523
Disease: Malabsorption Syndrome
Malabsorption Syndrome
0.130 Biomarker group HPO
CUI: C0011991
Disease: Diarrhea
Diarrhea
0.110 Biomarker phenotype HPO
CUI: C0392525
Disease: Nephrolithiasis
Nephrolithiasis
0.100 Biomarker disease HPO
CUI: C1963165
Disease: Malabsorption, CTCAE
Malabsorption, CTCAE
0.100 Biomarker phenotype HPO
CUI: C3714745
Disease: Malabsorption
Malabsorption
0.100 Biomarker phenotype HPO
Abnormality of metabolism/homeostasis
0.100 Biomarker phenotype HPO
CUI: C0017921
Disease: Glycogen storage disease type II
Glycogen storage disease type II
0.100 AlteredExpression disease BEFREE If compared with infantile AMD (Pompe's disease) our cases have a much higher residual acid alpha-glucosidase activity and show the presence of an antigenically detectable protein. 60470 1976
Generalized glycogen storage disease of infants
0.100 AlteredExpression disease BEFREE If compared with infantile AMD (Pompe's disease) our cases have a much higher residual acid alpha-glucosidase activity and show the presence of an antigenically detectable protein. 60470 1976
CUI: C0017921
Disease: Glycogen storage disease type II
Glycogen storage disease type II
0.100 AlteredExpression disease BEFREE alpha-glucosidase activity in human leucocytes: choice of lymphocytes for the diagnosis of Pompe's disease and the carrier state. 361294 1978
Generalized glycogen storage disease of infants
0.100 AlteredExpression disease BEFREE alpha-glucosidase activity in human leucocytes: choice of lymphocytes for the diagnosis of Pompe's disease and the carrier state. 361294 1978
CUI: C0017921
Disease: Glycogen storage disease type II
Glycogen storage disease type II
0.100 AlteredExpression disease BEFREE Hybrids between thymidine kinase-deficient mouse cells and fibroblasts from a patient with Pompe disease that contained human chromosome 17 were found not to express human acid alpha-glucosidase. 388444 1979
Generalized glycogen storage disease of infants
0.100 AlteredExpression disease BEFREE Hybrids between thymidine kinase-deficient mouse cells and fibroblasts from a patient with Pompe disease that contained human chromosome 17 were found not to express human acid alpha-glucosidase. 388444 1979
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 AlteredExpression disease BEFREE Moreover, alpha-glucosidase levels in cystic fibrosis patients correlated with the degree of clinical impairment as measured by the Schwachman score. 110502 1979
CUI: C0026850
Disease: Muscular Dystrophy
Muscular Dystrophy
0.010 Biomarker disease BEFREE It remains unknown whether or not the enzyme deficiency in homozygotes for isozyme 2 of acid alpha-glucosidase will be sufficient to cause glycogen accumulation and lead to the development of muscular dystrophy-like disease later in life. 6401921 1983
CUI: C0017921
Disease: Glycogen storage disease type II
Glycogen storage disease type II
0.100 AlteredExpression disease BEFREE Double immunodiffusion studies showed the presence of catalytically inactive acid alpha-glucosidase enzyme protein in canine GSD II. 6391168 1984
CUI: C0017921
Disease: Glycogen storage disease type II
Glycogen storage disease type II
0.100 Biomarker disease BEFREE Demonstration of acid alpha-glucosidase in different types of Pompe disease by use of an immunochemical method. 6442343 1985
CUI: C0017921
Disease: Glycogen storage disease type II
Glycogen storage disease type II
0.100 Biomarker disease BEFREE Diagnosis of Pompe's disease using leukocyte preparations. Kinetic and immunological studies of 1,4-alpha-glucosidase in human fetal and adult tissues and cultured cells. 3891151 1985
Generalized glycogen storage disease of infants
0.100 Biomarker disease BEFREE Diagnosis of Pompe's disease using leukocyte preparations. Kinetic and immunological studies of 1,4-alpha-glucosidase in human fetal and adult tissues and cultured cells. 3891151 1985
Generalized glycogen storage disease of infants
0.100 Biomarker disease BEFREE Demonstration of acid alpha-glucosidase in different types of Pompe disease by use of an immunochemical method. 6442343 1985
CUI: C0017921
Disease: Glycogen storage disease type II
Glycogen storage disease type II
0.100 Biomarker disease BEFREE Genetic deficiency of acid alpha-glucosidase results in glycogen-storage disease type II, encompassing a spectrum of disorders of varying severity. 3540946 1986
CUI: C0017921
Disease: Glycogen storage disease type II
Glycogen storage disease type II
0.100 Biomarker disease BEFREE First trimester diagnosis of Pompe's disease (glycogenosis type II) with normal outcome: assay of acid alpha-glucosidase in chorionic villous biopsy using antibodies. 3098466 1986
Generalized glycogen storage disease of infants
0.100 Biomarker disease BEFREE First trimester diagnosis of Pompe's disease (glycogenosis type II) with normal outcome: assay of acid alpha-glucosidase in chorionic villous biopsy using antibodies. 3098466 1986
Generalized glycogen storage disease of infants
0.100 Biomarker disease BEFREE Genetic deficiency of acid alpha-glucosidase results in glycogen-storage disease type II, encompassing a spectrum of disorders of varying severity. 3540946 1986
CUI: C0017921
Disease: Glycogen storage disease type II
Glycogen storage disease type II
0.100 Biomarker disease BEFREE Total RNA from a patient with the adult form of glycogenosis type II is not able to direct the synthesis of normal amounts of alpha-glucosidase in vitro. 3315002 1987